LIVE VIEW · VYNEYarrow Bioscience, Inc.HealthcareVYNE research Sign up to open the full interactive terminal, save boards, and get alerts
VYNE · Live chart
Loading live chart
VYNE · Smart-money compositeas of Aug 14
+26LONGsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
VYNE · Recent signals
RENAISSANCE TECHNOLOGIES LLC new position in VYNEMEDIUMLONGJul 24
TWO SIGMA INVESTMENTS, LP added +94% to VYNE (2026Q1)HIGHLONGJul 24
Q4-2025: Beat consensus by 38.5% - EPS $-0.11292 vs $-0.1836 estimateMEDIUMLONGJun 19
Q3-2025: Missed consensus by 28.2% - EPS $-0.17 vs $-0.1326 estimateMEDIUMSHORTMay 31
Q1-2026: Beat consensus by 56.4% - EPS $-0.08 vs $-0.1836 estimateMEDIUMLONGMay 31
Q2-2025: Beat consensus by 42.9% - EPS $-0.13 vs $-0.2278 estimateMEDIUMLONGMay 31
Q1-2026: Beat consensus by 38.5% - EPS $-0.11292 vs $-0.1836 estimateMEDIUMLONGMay 31
VYNE · Institutional holdersas of 2026Q1
TWO SIGMA INVESTMENTS, LP$255K+93.8%
TWO SIGMA INVESTMENTS, LP$128K-0.4%
TWO SIGMA INVESTMENTS, LP$74Kn/a
CITADEL ADVISORS LLC$18Kn/a
RENAISSANCE TECHNOLOGIES LLC$10Kn/a
Live alerts on VYNE
Live alerts on VYNEGet pinged the moment insiders, congress, or 13F funds move on VYNE.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for VYNE.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock